Market revenue in 2023 | USD 466.3 million |
Market revenue in 2030 | USD 760.9 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Research & Manufacturing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Research & Manufacturing |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Roche Holding AG, Qiagen NV, Becton Dickinson & Co, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Hologic Inc, Koninklijke Philips NV, Illumina Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 68.63% in 2023. Horizon Databook has segmented the Latin America blood cancer diagnostics market based on hospitals, outpatient facilities, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The expansion of healthcare infrastructure and increased investment in the healthcare sector are propelling the growth of the blood cancer diagnostics market in Latin America. Many countries in the region are witnessing improvements in their healthcare systems, including the establishment of specialized cancer treatment centers and the modernization of diagnostic laboratories.
In October 2023, The Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) launched the Latin America and the Caribbean Code Against Cancer. This new Code, as part of the World Code Against Cancer, aimed to alleviate the cancer burden in the region by offering recommendations grounded in the latest scientific evidence.
The development of this Code results from collaborative effort between PAHO and IARC, involving a large group of scientific experts from the region who reviewed the evidence and formulated recommendations for optimal cancer prevention.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America blood cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account